Navigation Links
Workshop on R&D for rapid vaccine development and production in Asia/Australia
Date:3/31/2010

Arlington, VA, March 18, 2010. How did China and Australia develop and produce swine flu vaccine months before North America and Europe? A panel of U.S. experts will try to answer this question and report on other comparative findings in a workshop at the National Science Foundation (NSF) in Arlington, VA, on May 5, 2010.

Under the sponsorship of the National Science Foundation and other Federal agencies, the World Technology Evaluation Center, Inc. (WTEC), commissioned the Asia/Australia phase of worldwide advances in vaccine development and production for the spring of 2010. The European and North American study of the field was completed and reported in 2007.

The findings of the Asia/Australia phase will be presented at a workshop on May 5 2010, 8:30 am 4:00 pm, at the National Science Foundation, Stafford II, Room 555, 4201 Wilson Boulevard, Arlington, VA, 22230. Although the workshop is free, registration is required for security purposes. For further information and registration visit: http://www.wtec.org/vaccine2/ .

The expert panel was chaired by Joseph Bielitzki, DVM, University of Central Florida and included Stephen W. Drew, Ph.D., member National Academy of Engineering, Drew Solutions; Cyril Gay, DVM, U.S. Department of Agriculture; Terrance Leighton, Ph.D., Senior Scientist, Children's Hospital Oakland Research Institute (CHORI); Mary Ritchie, Ph.D., Ritchie Associates, Inc.; Sheldon H. Jacobson, Ph.D., Professor University of Illinois Urbana-Champaign; accompanied by agency representative Narayan Iyer, Ph.D., Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health and Human Services (HSS).

The panel, which also conducted the European phase of the study, will report on visits to more than 20 academic and industrial institutions and interviews with government policy makers in Japan, China, South Korea, and Australia. The panel will also compare findings in vaccine development and production among these countries and Europe and North America.

The full text of the completed WTEC international reports on rapid vaccine manufacturing in Europe, and many others are available free at http://wtec.org.


'/>"/>

Contact: Patricia Foland
pfoland@scienceus.org
410-467-9832
World Technology Evaluation Center
Source:Eurekalert

Related biology news :

1. Workshops on biotechnology and water for science journalists
2. ESFs workshop restores good name of sugar
3. Iridescence workshop promotes natures nanotechnology
4. Workshop assesses interactions between climate, forests and land use in the Amazon Basin
5. International workshop to address capacity building for rainforest leaders
6. Dartmouth workshop sets research agenda for environmental mercury
7. Workshop on environmental nanoparticles at UD, Nov. 10-11
8. Entrepreneurs wanted for NJIT workshops about how to launch a business
9. NSF-funded workshops help young researchers teach science
10. Experts lay to rest long-held misconceptions about high fructose corn syrup at ILSI-USDA workshop
11. K-State host to workshop on rapid methods to detect microorganisms in food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... , December 5, 2016 ... Expansion Market, by Products (Consumable, Instruments, Automated Cell ... Medicine and Stem Cell Research, Cancer, and Cell-Based ... Cell Banks) - Global Revenue, Trends, Growth, Share, ... Market Research, the global cell expansion market is ...
(Date:12/5/2016)... 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... and Safety Monitoring Board (DSMB) for the Company,s ... (CVD) patients has completed a second planned safety ... as planned without any modifications. The DSMB reviewed ... or efficacy concerns were identified. The DSMB will ...
(Date:12/5/2016)... LAKE, N.J. , Dec. 5, 2016 /PRNewswire/ ... Phase 3 open-label two-year study of rufinamide, which ... the American Epilepsy Society (AES) held from December ... Analysis of final two-year safety, tolerability and cognitive ... with rufinamide experienced similar safety and tolerability profiles, ...
(Date:12/5/2016)... , December 5, 2016 ... worldwide, with almost $108 billion of revenue and some ... billion were spent on global biopharmaceuticals, and this figure ... morning, Stock-Callers.com has lined up these four equities for ... ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda ...
Breaking Biology Technology: